LifeStance Health Group Financial Ratios
NASDAQ: LFSTHealth CareMedical/Nursing ServicesUSD
12.42+0.36 (+2.99%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LifeStance Health Group ratio analysis
LifeStance Health Group earned a net margin of 0.7% in FY 2025, up from -4.6% a year earlier. Return on equity reached 0.6%, meaning LifeStance Health Group generated 0.01 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.18 versus 0.20 the year before, and the current ratio was 1.65.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
LifeStance Health Group financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 348.00 | — | — | — | — | — |
| Price / sales | 1.89 | 2.38 | 2.73 | 2.04 | 0.00 | — |
| Price / book | 1.77 | 2.06 | 2.01 | 1.16 | 0.00 | — |
| Operating margin | 1.7% | -2.5% | -17.9% | -24.5% | -42.9% | 7.2% |
| Net margin | 0.7% | -4.6% | -17.6% | -25.1% | -46.0% | 2.7% |
| Free cash flow margin | 7.7% | 6.9% | -5.4% | -3.1% | -12.7% | 1.3% |
| Return on equity (ROE) | 0.6% | -4.0% | -13.0% | -14.2% | -19.9% | — |
| Return on assets (ROA) | 0.4% | -2.7% | -8.8% | -9.9% | -15.9% | — |
| Debt / equity | 0.18 | 0.20 | 0.20 | 0.15 | 0.10 | — |
| Current ratio | 1.65 | 1.37 | 1.11 | 1.33 | 2.28 | — |
| Revenue growth | 13.9% | 18.5% | 22.8% | 28.8% | 214.1% | — |